Issue 3/2013
Content (19 Articles)
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
Don Husereau, Michael Drummond, Stavros Petrou, Chris Carswell, David Moher, Dan Greenberg, Federico Augustovski, Andrew H. Briggs, Josephine Mauskopf, Elizabeth Loder
Redistributional consequences of early childhood intervention
Tim Lohse, Peter F. Lutz, Christian Thomann
Problems of priority change in kidney allocation and beyond
Marlies Ahlert, Hartmut Kliemt
Terminal patients in Belgian nursing homes: a cost analysis
Steven Simoens, Betty Kutten, Emmanuel Keirse, Paul Vanden Berghe, Claire Beguin, Marianne Desmedt, Myriam Deveugele, Christian Léonard, Dominique Paulus, Johan Menten
Effects of competition on hospital quality: an examination using hospital administrative data
Alfons Palangkaraya, Jongsay Yong
Welfare-related health inequality: does the choice of measure matter?
Joachim R. Frick, Nicolas R. Ziebarth
Diffusion of innovations in social interaction systems. An agent-based model for the introduction of new drugs in markets
Julio Pombo-Romero, Luis M. Varela, Carlos J. Ricoy
Does the US health care safety net discourage private insurance coverage?
Xuezheng Qin, Gordon G. Liu
The impact of time cost of physical exercise on health outcomes by older adults: the DR’s EXTRA Study
Virpi Kuvaja-Köllner, Hannu Valtonen, Pirjo Komulainen, Maija Hassinen, Rainer Rauramaa
Cost-effectiveness analysis of dronedarone versus other anti-arrhythmic drugs for the treatment of atrial fibrillation—results for Canada, Italy, Sweden and Switzerland
Jonas Nilsson, Örjan Åkerborg, Gaëlle Bégo-Le Bagousse, Mårten Rosenquist, Peter Lindgren
Drug expenditure of high-cost patients and their characteristics in Finland
Leena K. Saastamoinen, Jouko Verho
Systems GMM estimates of the health care spending and GDP relationship: a note
Saten Kumar
Lenalidomide for multiple myeloma: cost-effectiveness in patients with one prior therapy in England and Wales
Ruth E. Brown, Sean Stern, Sujith Dhanasiri, Steve Schey
Spending more money, saving more lives? The relationship between avoidable mortality and healthcare spending in 14 countries
Richard Heijink, Xander Koolman, Gert P. Westert
How to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus
Thomas Wilke, Antje Groth, Sabrina Mueller, Dallas Reese, Roland Linder, Susanne Ahrens, Frank Verheyen